Results 141 to 150 of about 48,011 (239)

Platelet Alloantibody Specificities in Multiply Transfused Patients. [PDF]

, 2008
Transfusion plays an important role in the management of patients with hematological malignancies and disorders. Patients during the induction chemotherapy may need multiple transfusion of platelets and red cells and may develop refractoriness ...
Madhan Kumar, B K
core  

Immune platelet transfusion refractoriness in pediatric patients undergoing HSCT

Egyptian Pediatric Association Gazette
Background Children who undergo hematopoietic stem cell transplantation (HSCT) sometimes have immune platelet transfusion refractoriness (IPTR). The thrombopoietin receptor agonist (TPO-RA) is used to increase platelet counts in a variety of immune ...
Olivera Serbic, Zorana Andric, Svetlana Vojvodic, Dragomir Djokic, Marija Simic   +4 more
doaj   +1 more source

The Frequency and Characteristics of the Platelet Refractoriness and Alloimmunization in Platelet Concentrate Multiple-Transfused Thrombocytopenic Patients

, 1999
BACKGROUND: Understanding the cause for platelet refractoriness in a given patient is the critical step in determining the strategy for optimum management. The aim of this study was to establish the causes and frequency of platelet refractoriness as well
용동은, 김현옥, 김현숙
core  

Supply chain management of blood products: a literature review. [PDF]

This paper presents a review of the literature on inventory and supply chain management of blood products. First, we identify different perspectives on approaches to classifying the existing material. Each perspective is presented as a table in which the
Forcé, Hein, Belien, Jeroen
core  

Slot blotting and flow cytometry: two efficient assays for platelet antibody screening among patients with platelet refractoriness

, 2020
Background and Objectives: Frequent platelet transfusion may lead to the formation of alloantibodies and immune-mediated platelet destruction. Currently, identifying economic and effective screening methods is necessary for the management of platelet ...
Ameri, Z., Vahidi, R., Khaleghi, M., Farsinejad, A., Dehesh, T., Sheikhbardsiri, A.   +5 more
core  

Platelet desialylation, apoptosis, and T-lymphocyte-mediated immune dysregulation: unveiling the pathways of platelet clearance in platelet transfusion refractoriness. [PDF]

Res Pract Thromb Haemost
Zhou Y, Zhong Z, Mo H, Liang L, Su C, Chen Y, Lu F, Huang Y, Wu G.   +8 more
europepmc   +1 more source

Marked platelet transfusion refractoriness caused by anti-HLA-I and anti-HPA-5b antibodies: A case report. [PDF]

Medicine (Baltimore)
Wang Y, Liu Z, Duan S, Lin C, Jin Y, Wang H, Wang Y, Tang L, Wang M.   +8 more
europepmc   +1 more source

Platelet reactive alloantibodies responsible for immune thrombocytopenia in Malay population

Background: Alloantibodies against human platelet alloantigens (HPAs) are responsible for the development of platelet transfusion refractoriness (PTR) in patientsreceiving random platelets and bleeding disorder in babies with fetal neonatal alloimmune ...
Afifah Hassan, Hevi Wihadmadyatami, Sentot Santoso, Mohd I. Armawai   +3 more
core  

The Preparation of Platelet Panel using DNA genotyping

, 1997
Background : The serum should be tested with a platelet panel for identification of platelet specific alloantibodies. Such platelet panels are not available from commercial sources and can usually be made using platelets from local donor population.
김현옥
core  

Plenary Abstracts Session & Oral Presentations

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source